Navigation Links
China Sky One Medical, Inc. Interviewed in The China Perspective
Date:12/5/2008

HARBIN, China, Dec. 5 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced today that Mr. Yan-Qing Liu, Chairman, CEO and President of China Sky One Medical took part in an insightful interview in today's issue of The China Perspective.

As a well-known pharmaceutical company in China, China Sky One was honored to receive an interview from The China Perspective, a leading source of China business news, research and analysis that provides insight into the trends, companies and industries that are shaping the Chinese economy. During the interview, Mr. Yan-Qing Liu spoke about the Company's recent acquisitions, its R&D capability and the impact of global financial crisis on pharmaceutical producers. For more information, please visit The China Perspective's website ( http://www.thechinaperspective.com ).

"This is an exciting time in the evolution of the pharmaceutical industry in China, and China Sky One is well positioned to offer insight as a leading drug manufacturer and distributor in China," commented Mr. Yan-Qing Liu, Chairman, CEO and President of China Sky One Medical. "We are thrilled to work with The China Perspective and to share our reflections about the global economic crisis and our expertise in the Chinese pharmaceutical market with the investment community."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiari
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCal...d its financial results for the third quarter ende...f $3.6 million ($0.04 per share) for the three mon...s of $6.8 million ($0.08 per share) in the compara...tember 30, 2009, GenVec,s net loss was $14.1 milli...
(Date:11/5/2009)..., RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-Fir... leading supplier of innovative products for proce... results for the first quarter of fiscal 2010. ,...ompany reported revenues of $5.2 million, a 15 per... first quarter a year ago. The Company said the ke...
(Date:11/5/2009)..., SUNNYVALE, Calif., Nov. 5 /PRNewswire-FirstCal...t its executives will be speaking at the following...rticipate via webcast. , , Credit ... Thursday, 12 November, 2009 at 10 a.m. Mo...stor Program, London, England, Tue...
(Date:11/5/2009)..., AUSTIN, Texas, Nov. 5 SpineSmi...enOsteo, Inc. to co-develop a unique scaffold that... Following evaluation of several commercial produc...ment, the company believes the GenOsteo scaffold r...that creates a unique and ideal environment for th...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...rushing into the adoption of electronic medical re...cern for data security? , ,The question has been r...e some bills seek to provide incentives to encoura...ords, and others that raise privacy concerns are c...Moreover, headline-grabbing data breaches in both ...
...Corp. has been awarded a Phase II SBIR grant wort...logy for clinical research and possible diagnostic...nce company engaged in gene therapy and the study ...rom the National Institute of General Medical Sci...ween Mirus Bio scientist Mary Anne Watt and Gregor...
...al knows the missing link in many software evaluat...the implementation. , ,Cagigal, chief information ...d technologists who miscalculate return on investm... costs, which will exceed the implementation cost ...al It,s easy to pinpoint the pre-implementation c...
Other Biology Technology:Privacy, trust still the biggest barriers to electronic record sharing 2Privacy, trust still the biggest barriers to electronic record sharing 3The business case for software applications 2The business case for software applications 3
(Date:11/4/2009)...s out, hold the power to help militaries and munit...p toxic waste on test sites. , Compounds known a... in World War II and have been used in military mu...are often used to propel tank shells and act like ...reased knowledge of their environmentally harmful ...
(Date:11/4/2009)...s received more than $10 million in research grant...l stimulus program, bringing thetotal amount of st...illion. Thirty-three projects achieved stimulus f...ther. , "The university has thoughtfully underta...larly excellence to federal agency priorities. Th...
(Date:11/4/2009)...FirstCall/ -- Quest Diagnostics Incorporated (NYSE...ic testing, information and services, announced th... income from continuing operations rose to $192 mi...on, or $0.81 per diluted share, for the third quar...educed by a $0.03 per share charge associated with...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Unprecedented Merger Occurs in Retained Physician Search Industry 47441 1Unprecedented Merger Occurs in Retained Physician Search Industry 47441 2Unprecedented Merger Occurs in Retained Physician Search Industry 47441 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 1Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 2Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 4Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 5Religious devotion does not impact abortion decisions of young unwed women 47440 1Religious devotion does not impact abortion decisions of young unwed women 47440 2
...ng held by plants has been revealed by Howard Hugh...y, which builds on more than a decade of painstaki...different types of plant tissues, shows clearly fo...e research, conducted by Sigal Savaldi-Goldstein a...anne Chory at The Salk Institute for Biological St...
... at Johns Hopkins have discovered how cells fine-t...nt is available at the moment. , Too little oxygen...power it, so when oxygen is scarce, cells appear t...fficient substitute that "is specialized to keep t... out of gas," says Gregg Semenza, M.D., Ph.D., a p...
...ndred years after the first vitamin was named, wha...ficial, standardized recommendations for public he...or, and director of the Nutrition and Neurocogniti...on Research on Aging (USDA HNRCA) at Tufts Univers...titutes of Health State-of-the- Science Conference...
Other Biology News:Researchers learn what sparks plant growth 2Researchers learn what sparks plant growth 3Need oxygen? Cells know how to spend and save 2Vitamins: Science doesn't always match policy 2
Mouse Anti-Human Relaxin-2, pro- Monoclonal Antibody, Unconjugated, Clone fred from Immundiagnostik
Rabbit Anti-Chicken IgY, IgG F(ab')2 fragment Antibody, Rhodamine Conjugated from Biomeda Corporation
Goat Anti-Human Presenilin 2 Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-TWIK-2 (Kcnk6, TOSS) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: